Copeptin for Discriminating Two-Year Mortality in Heart Failure Patients with Moderate to Severe Systolic Dysfunction

João Silva Marques^1,2*, Ana G. Almeida¹, Cláudio David¹, Henrique Luz-Rodrigues^2,3 and António Nunes Diogo¹

¹Hospital Santa Maria, Cardiology, Lisbon Academic Medical Centre, CCUL(Centro de Cardiologia da Universidade de Lisboa), Lisbon, Portugal

²Lisbon University Medical School, Department of Pharmacology and Neurosciences, Lisbon Academic Medical Centre, Lisbon, Portugal

³Hospital Santa Maria, Nephrology, Lisbon Academic Medical Center - Av Prof. Egas Moniz, Lisbon, Portugal

^*Corresponding Author: Dr. João Silva Marques, M.D, Hospital Santa Maria, Cardiology, Lisbon Academic Medical Centre, CCUL (Centro de Cardiologia da Universidade de Lisboa), Lisbon, Portugal, Tel: (+351)916060822 Email: